Our study of locally advanced and metastatic RCC, although showing a trend of poorer prognosis in higher Ki67 expression, failed to demonstrate any significant difference in CSS based on Ki67 expression. The gene discussed is MKI67; the disease is renal cell adenocarcinoma.